ArticleDialogues in health2025
Workplace menstrual product policies and worker well-being: Insights from Queensland, Australia.
Article in Dialogues in health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Financial burden of menstrual and menopausal symptoms: productivity loss from absenteeism and presenteeism among working-age women.Reproductive health · 2026Article
- Measuring menstrual hygiene in high-income countries: A scoping review.Women's health (London, England)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2022, the World Health Organization acknowledged menstrual health as a global human right and encouraged a shift in responsibility from individuals to the community. Globally, menstrual products are rarely included in workplace policies, hindering equitable well-being by placing disproportionate burden on menstruating workers. This exploratory study in Queensland, Australia supplied a public sector workplace with menstrual products for two months in 2023. A questionnaire with qualitative and quantitative aspects assessed the experiences of 21 menstruating workers. Before the supply, 94.7 % had experienced menstruation at work without access to products, leading to mental distress. Additionally, 71.4 % worried about lacking products when needed and 38.1 % believed this worry decreased their mental well-being or concentration. After the supply, 94.1 % reported improved emotions, 70.6 % perceived improved concentration and 64.7 % felt improved mental well-being. However, only 57.1 % believed that menstrual product supply should be mandated by workplace policy. Factors contributing to exclusion of menstrual products from global workplace policies are discussed, such as limited awareness, poor workplace infrastructure and persistent stigma. This study was limited by a small sample size and self-reporting bias. Regardless, the findings highlight the respective positive and negative impacts of including or omitting menstrual products in workplace policy, even in a socioeconomically privileged country like Australia. This emphasises the underestimation of menstrual health as a basic human right in workplace health and safety, urging more research on workplace menstrual product provision and related feminine sanitary infrastructure especially in low-resourced nations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.